報價延遲最少15分鐘:2025/03/28 05:18 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
26.53 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.34/-2.18
|
|
企業價值
719.41M
|
| 資產負債 |
|
每股賬面淨值
7.41
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/03/28 05:18 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, theinevitable loss of near vision that impacts the daily lives of nearly all people over 45. |